Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.17028 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Sukjung Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, U…. Hauptthemen laut MEDLINE: Nitroimidazoles, Dog Diseases, Chagas Disease, Trypanosoma cruzi. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, George Robinson Foundation, NCATS NIH HHS.
Abstract (Originalsprache)
Trypanosoma cruzi infection in dogs can cause heart failure and sudden death with few treatment options available. A litter of 4 dogs living in a T cruzi endemic area were randomized to prophylaxis and nonprophylaxis groups as part of a study evaluating a modified benznidazole dosing regimen administered twice weekly to prevent T cruzi infection during a vector transmission season. The 2 dogs that received prophylaxis remained healthy without T cruzi infection or cardiac disease for >2 years. One dog that did not receive prophylaxis died unexpectedly with acute T cruzi–induced pancarditis, and the second dog tested positive for T cruzi and developed complex arrhythmias with markedly increased cardiac troponin I and improved with a higher benznidazole treatment dose. Although the small sample size precludes definitive conclusions, we describe the potential clinical benefit of prophylactic and early treatment with modified benznidazole dosing regimens for dogs with T cruzi infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
- Jourdanton, Texas, USA.
- Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Research, Texas A&M University, College Station, Texas, USA.
- Center for Tropical and Emerging Global Diseases and Department of Cellular Biology, University of Georgia, Athens, Georgia, USA.
ORCID-Profile: Sukjung Lim, Ashley B Saunders
Förderung
- NIH HHS
- George Robinson Foundation
- NCATS NIH HHS
- Veterinary Pharmacology Research Foundation
- American Veterinary Medical Foundation
- NIH
Zitieren
APA
Lim, S., Collins, S., Hamer, S. A., Tarleton, R. L., & Saunders, A. B. (2024). Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17028
Vancouver
Lim S, Collins S, Hamer SA, Tarleton RL, Saunders AB. Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17028
BibTeX
@article{Lim2024,
author = {Lim, Sukjung and Collins, Stephanie and Hamer, Sarah A and Tarleton, Rick L and Saunders, Ashley B},
title = {Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.17028}
}
EUVIMED